Oxford BioDynamics Plc
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor i… Read more
Oxford BioDynamics Plc (OXBOF) - Total Assets
Latest total assets as of September 2025: $10.87 Million USD
Based on the latest financial reports, Oxford BioDynamics Plc (OXBOF) holds total assets worth $10.87 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Oxford BioDynamics Plc - Total Assets Trend (2013–2025)
This chart illustrates how Oxford BioDynamics Plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Oxford BioDynamics Plc - Asset Composition Analysis
Current Asset Composition (September 2025)
Oxford BioDynamics Plc's total assets of $10.87 Million consist of 28.2% current assets and 71.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 17.2% |
| Accounts Receivable | $932.87K | 8.6% |
| Inventory | $195.00K | 1.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.11 Million | 10.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Oxford BioDynamics Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Oxford BioDynamics Plc's current assets represent 28.2% of total assets in 2025, a decrease from 97.2% in 2013.
- Cash Position: Cash and equivalents constituted 17.2% of total assets in 2025, down from 83.9% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 10.2% of total assets.
Oxford BioDynamics Plc Competitors by Total Assets
Key competitors of Oxford BioDynamics Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Oxford BioDynamics Plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Oxford BioDynamics Plc generates 0.10x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Oxford BioDynamics Plc is currently not profitable relative to its asset base.
Oxford BioDynamics Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.18 | 1.97 | 10.01 |
| Quick Ratio | 1.08 | 1.84 | 9.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $460.12K | $ 2.48 Million | $ 11.60 Million |
Oxford BioDynamics Plc - Advanced Valuation Insights
This section examines the relationship between Oxford BioDynamics Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.64 |
| Latest Market Cap to Assets Ratio | 1.13 |
| Asset Growth Rate (YoY) | -10.2% |
| Total Assets | $10.87 Million |
| Market Capitalization | $12.26 Million USD |
Valuation Analysis
Above Book Valuation: The market values Oxford BioDynamics Plc's assets above their book value (1.13 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Oxford BioDynamics Plc's assets decreased by 10.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Oxford BioDynamics Plc (2013–2025)
The table below shows the annual total assets of Oxford BioDynamics Plc from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $10.87 Million | -10.23% |
| 2024-09-30 | $12.11 Million | -24.92% |
| 2023-09-30 | $16.13 Million | +42.16% |
| 2022-09-30 | $11.34 Million | -26.24% |
| 2021-09-30 | $15.38 Million | +0.17% |
| 2020-09-30 | $15.35 Million | -18.30% |
| 2019-09-30 | $18.79 Million | -10.26% |
| 2018-09-30 | $20.94 Million | +65.16% |
| 2017-09-30 | $12.68 Million | +40.57% |
| 2016-09-30 | $9.02 Million | -7.39% |
| 2015-09-30 | $9.74 Million | +57.53% |
| 2014-09-30 | $6.18 Million | +71.85% |
| 2013-09-30 | $3.60 Million | -- |